HK1220326A1 - 基於網絡微生物組成和方法 - Google Patents
基於網絡微生物組成和方法Info
- Publication number
- HK1220326A1 HK1220326A1 HK16108497.3A HK16108497A HK1220326A1 HK 1220326 A1 HK1220326 A1 HK 1220326A1 HK 16108497 A HK16108497 A HK 16108497A HK 1220326 A1 HK1220326 A1 HK 1220326A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- network
- methods
- microbial compositions
- based microbial
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361798666P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/030817 WO2014145958A2 (en) | 2013-03-15 | 2014-03-17 | Network-based microbial compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220326A1 true HK1220326A1 (zh) | 2017-05-05 |
Family
ID=51538577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108497.3A HK1220326A1 (zh) | 2013-03-15 | 2016-07-18 | 基於網絡微生物組成和方法 |
Country Status (7)
Country | Link |
---|---|
US (3) | US10076546B2 (zh) |
EP (1) | EP2967077A4 (zh) |
JP (3) | JP2016519664A (zh) |
AU (3) | AU2014232370B2 (zh) |
CA (1) | CA2906921A1 (zh) |
HK (1) | HK1220326A1 (zh) |
WO (1) | WO2014145958A2 (zh) |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
EP2785828B1 (en) | 2011-12-01 | 2020-04-08 | The University of Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
EP2830599B1 (en) | 2012-03-29 | 2018-08-15 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
WO2014121304A1 (en) | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
JP2016519664A (ja) | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | ネットワークを基にした微生物組成物及び方法 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10633714B2 (en) | 2013-07-21 | 2020-04-28 | Pendulum Therapeutics, Inc. | Methods and systems for microbiome characterization, monitoring and treatment |
KR102515850B1 (ko) | 2013-11-25 | 2023-03-30 | 세레스 테라퓨틱스, 인코포레이티드 | 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도 |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
US10206958B2 (en) | 2014-04-23 | 2019-02-19 | Cornell University | Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract |
CN107075446B (zh) * | 2014-09-30 | 2022-01-21 | 深圳华大基因科技有限公司 | 用于肥胖症相关疾病的生物标记物 |
US9703929B2 (en) | 2014-10-21 | 2017-07-11 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
US10346592B2 (en) | 2014-10-21 | 2019-07-09 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
US10357157B2 (en) | 2014-10-21 | 2019-07-23 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features |
US10395777B2 (en) | 2014-10-21 | 2019-08-27 | uBiome, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
JP6868562B2 (ja) | 2014-10-31 | 2021-05-19 | ペンデュラム セラピューティクス, インコーポレイテッド | 障害の微生物的処置および診断に関する方法および組成物 |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
DK3193901T3 (en) | 2014-12-23 | 2018-05-28 | 4D Pharma Res Ltd | PIRIN POLYPEPTIDE AND IMMUNMODULATION |
CN108138122B (zh) | 2014-12-23 | 2021-09-21 | 4D制药研究有限公司 | 免疫调控 |
WO2016138337A1 (en) * | 2015-02-27 | 2016-09-01 | Nawana Namal | Microbiome diagnostics |
EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
WO2016196605A1 (en) | 2015-06-01 | 2016-12-08 | The University Of Chicago | Treatment of cancer by manipulation of commensal microflora |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
PL3307289T3 (pl) | 2015-06-09 | 2022-01-17 | Rebiotix, Inc. | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
WO2016203223A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
DK3307288T3 (da) | 2015-06-15 | 2019-10-07 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
PT3240554T (pt) | 2015-06-15 | 2019-11-04 | 4D Pharma Res Ltd | Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes |
EP3344072B1 (en) * | 2015-09-04 | 2023-03-08 | Memorial Sloan Kettering Cancer Center | Methods for detecting risk of cancer relapse using eubacterium limosum |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
PL3209310T3 (pl) | 2015-11-20 | 2018-08-31 | 4D Pharma Research Limited | Kompozycja zawierająca szczepy bakteryjne |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
US11492672B2 (en) * | 2015-12-04 | 2022-11-08 | Biome Makers Inc. | Microbiome based identification, monitoring and enhancement of fermentation processes and products |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
WO2017116235A1 (en) * | 2015-12-31 | 2017-07-06 | Caelus Pharmaceuticals B.V. | Method for culturing and preserving eubacterium hallii |
CN105524907B (zh) * | 2016-02-01 | 2018-12-04 | 江南大学 | 一种底物专一性提高的胆盐水解酶突变体 |
BR112018015097A2 (pt) | 2016-02-04 | 2018-12-26 | Universiteit Gent | composição e reatores |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
BR112018067689A2 (pt) | 2016-03-04 | 2019-01-08 | 4D Pharma Plc | composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral |
CN115919906A (zh) | 2016-03-04 | 2023-04-07 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
WO2017156031A1 (en) * | 2016-03-07 | 2017-09-14 | uBiome, Inc. | Method and system for characterizing mouth-associated conditions |
US11116804B2 (en) | 2016-03-14 | 2021-09-14 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
BR112018070380A2 (pt) * | 2016-04-05 | 2019-02-05 | Nch Corp | método de germinação de esporos bacterianos, e, composição germinativa de nutriente. |
AU2017249159A1 (en) * | 2016-04-11 | 2018-11-29 | President And Fellows Of Harvard College | Probiotic formulations for improving athletic performance |
EP3445857B1 (en) | 2016-04-20 | 2023-07-05 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
US9999641B2 (en) | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
KR101815692B1 (ko) | 2016-07-25 | 2018-01-16 | 주식회사 고바이오랩 | 구강 세균의 군집을 이용한 대사성 질환 진단용 바이오 마커 |
US10441612B2 (en) * | 2016-08-16 | 2019-10-15 | Taichung Veterans General Hospital | Intestinal microbe therapy, composition therefor and method for preparing the same |
JP6408092B2 (ja) * | 2016-08-29 | 2018-10-17 | 国立大学法人 東京大学 | 糞便微生物叢を含む組成物 |
CN109219656A (zh) * | 2016-09-06 | 2019-01-15 | 深圳华大生命科学研究院 | 长栖粪杆菌(Faecalibacterium longum)及其应用 |
US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
US10428370B2 (en) * | 2016-09-15 | 2019-10-01 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
FI20165932L (fi) | 2016-12-07 | 2018-06-08 | Univ Helsinki | Immunomodulatorisia koostumuksia |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
AU2017376780A1 (en) | 2016-12-15 | 2019-07-04 | Novome Biotechnologies, Inc. | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
US10783437B2 (en) * | 2017-03-05 | 2020-09-22 | International Business Machines Corporation | Hybrid aggregation for deep learning neural networks |
US10733214B2 (en) | 2017-03-20 | 2020-08-04 | International Business Machines Corporation | Analyzing metagenomics data |
CA3058943C (en) | 2017-04-03 | 2023-10-17 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
EP3388069B1 (en) | 2017-04-12 | 2019-05-01 | ETH Zurich | Consortia of living bacteria useful for treatment of microbiome dysbiosis |
EP3615078A1 (en) * | 2017-04-28 | 2020-03-04 | Emma Allen-Vercoe | Methods and compositions for storing bacteria |
KR20200019882A (ko) | 2017-05-22 | 2020-02-25 | 4디 파마 리서치 리미티드 | 세균 균주를 포함하는 조성물 |
TW201907931A (zh) | 2017-05-24 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物 |
JP6884889B2 (ja) | 2017-06-14 | 2021-06-09 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | 細菌株を含む組成物 |
ES2917415T3 (es) | 2017-06-14 | 2022-07-08 | 4D Pharma Res Ltd | Composiciones que comprenden una cepa bacteriana |
CN110892081A (zh) | 2017-07-17 | 2020-03-17 | 智能Dna股份有限公司 | 诊断菌群失调的方法 |
SG11202000589RA (en) * | 2017-08-04 | 2020-02-27 | Second Genome Inc | Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeutics |
KR20200037292A (ko) * | 2017-08-06 | 2020-04-08 | 세컨드 게놈, 아이엔씨. | 생물학적 치료제로서 스트렙토코크스 아루스트랄리스 |
AU2018313765A1 (en) * | 2017-08-07 | 2020-02-27 | Finch Therapeutics, Inc. | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut |
AU2018318132A1 (en) | 2017-08-14 | 2020-02-27 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
CA3073838A1 (en) | 2017-08-30 | 2019-03-07 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
WO2019089643A1 (en) * | 2017-10-30 | 2019-05-09 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
EP3723775A4 (en) * | 2017-12-15 | 2022-04-13 | Solarea Bio, Inc. | MICROBIAL COMPOSITIONS AND METHODS OF TREATMENT OF TYPE 2 DIABETES, OBESITY AND METABOLIC SYNDROME |
EP3750548A4 (en) * | 2018-02-09 | 2021-10-20 | Noster Inc. | LIPOPOLYSACCHARIDE-REGULATED ENTERIC BACTERIA AND THEIR USES |
WO2019178494A1 (en) * | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using tyzzerella nexilis |
WO2019199895A1 (en) | 2018-04-10 | 2019-10-17 | Siolta Therapeutics, Inc. | Microbial consortia |
US20210177916A1 (en) * | 2018-04-13 | 2021-06-17 | Med-Life Discoveries Lp | Long chain dicarboxylic fatty acid (lcdfa) producing microbes and uses thereof |
CN108977395B (zh) * | 2018-07-31 | 2022-03-22 | 李昕 | 钝化固化修复土壤六价铬污染的生物纳米材料的制备方法 |
CA3154314A1 (en) * | 2018-09-13 | 2020-03-19 | Gnubiotics Sciences Sa | Microbiome markers and uses thereof |
US20210386799A1 (en) * | 2018-09-25 | 2021-12-16 | Duke University | Methods and compositions to treat and prevent infection |
SG11202105284YA (en) * | 2018-11-21 | 2021-06-29 | Chan Zuckerberg Biohub Inc | High-complexity synthetic gut bacterial communities |
BR112021010895A2 (pt) * | 2018-12-05 | 2021-08-31 | Seres Therapeutics, Inc. | Composições para estabilização de bactérias e usos destas |
WO2020154397A1 (en) * | 2019-01-22 | 2020-07-30 | The Regents Of The University Of California | Bile acids and use in disease treatment |
US11270791B2 (en) * | 2019-03-30 | 2022-03-08 | Tata Chemicals Limited | In silico methods for obtaining nutraceutical compositions |
US20220257673A1 (en) * | 2019-07-19 | 2022-08-18 | Finch Therapeutics Holdings Llc | Methods and products for treatment of gastrointestinal disorders |
US20230057586A1 (en) * | 2019-08-16 | 2023-02-23 | Janssen Biotech, Inc. | Optimized culture media for clostridia bacteria |
CN114786690A (zh) * | 2019-10-07 | 2022-07-22 | 谢尔塔治疗公司 | 治疗性药物组合物 |
EP3808358A1 (en) * | 2019-10-17 | 2021-04-21 | University College Cork-National University of Ireland, Cork | Microbial compositions, strains and methods |
IL271775A (en) * | 2019-12-31 | 2021-06-30 | Biomica Ltd | A microbial consortium and its uses |
US20230035667A1 (en) * | 2020-01-17 | 2023-02-02 | Second Genome, Inc. | Methods and compositions for treating type 2 diabetes |
EP3875098A1 (en) * | 2020-03-04 | 2021-09-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Use of coprococcus bacteria for the treatment of metabolic syndrome and inflammatory bowel diseases |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
GB202007452D0 (en) * | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
US20230233620A1 (en) * | 2020-05-21 | 2023-07-27 | Chan Zuckerberg Biohub, Inc. | High-complexity synthetic gut bacterial communities |
CA3188645A1 (en) | 2020-08-14 | 2022-02-17 | Prolacta Bioscience, Inc. | Human milk oligosaccharide compositions for use with bacteriotherapies |
JP2023545458A (ja) * | 2020-10-14 | 2023-10-30 | ダームビオント インコーポレイテッド | 皮膚の健康状態の改善、ならびに、真菌および他の病原性マイクローブに関連する疾患、障害および疾病の処置および予防のための組成物および方法 |
US20240000859A1 (en) * | 2020-11-25 | 2024-01-04 | Seres Therapeutics, Inc. | Designed bacterial compositions for treating graft-versus-host-disease |
KR102296290B1 (ko) * | 2020-12-31 | 2021-09-01 | 주식회사 바이오뱅크힐링 | 비피도박테리움 아돌레센티스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN113337436A (zh) * | 2021-06-09 | 2021-09-03 | 中国科学院新疆生态与地理研究所 | 一种尿素分解菌及其选育方法和应用 |
CN113493847B (zh) * | 2021-06-24 | 2022-04-19 | 北京工业大学 | 基于PMA高通量测序和PICRUSt的抗生素抗性基因及潜在宿主细菌的鉴定方法 |
WO2023092150A1 (en) | 2021-11-22 | 2023-05-25 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
WO2023158917A2 (en) * | 2022-02-15 | 2023-08-24 | The Regents Of The University Of California | Methods, apparatus, and systems for determining the functional microbial niche and identifying interventions in complex hetergeneous communities |
JP7279983B1 (ja) | 2022-09-21 | 2023-05-23 | 学校法人近畿大学 | 腸内細菌培養組培地、及び腸内細菌培養方法。 |
Family Cites Families (162)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3009864A (en) | 1958-09-18 | 1961-11-21 | Union Carbide Corp | Process control |
US3228838A (en) | 1959-04-23 | 1966-01-11 | Union Carbide Corp | Preservation of biological substances |
US3009861A (en) | 1961-01-13 | 1961-11-21 | Alderton Gordon | Isolation of bacterial spores |
US3608030A (en) | 1969-05-21 | 1971-09-21 | Howard Tint | Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
US4077227A (en) | 1976-11-12 | 1978-03-07 | Regents Of The University Of Minnesota | Method of freezing liquid material in which agglomeration is inhibited |
US4205132A (en) | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
FI59925C (fi) | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae |
US4655047A (en) | 1985-03-25 | 1987-04-07 | I.Q.F. Inc. | Process for freezing or chilling |
JPS61252212A (ja) | 1985-04-12 | 1986-11-10 | Mitsubishi Petrochem Co Ltd | 高吸水性ポリマ−の製造方法 |
US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
JP2733849B2 (ja) | 1987-10-12 | 1998-03-30 | ボロディー,ソーマス・ユリウス | 胃腸障害治療のための改良された方法 |
US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
ATE165738T1 (de) | 1988-08-02 | 1998-05-15 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
GB2233343B (en) | 1989-06-30 | 1993-07-07 | Farmos Oy | A bacterial preparation for use in poultry |
JP2961182B2 (ja) | 1990-03-09 | 1999-10-12 | ミヤリサン株式会社 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
JP2961184B2 (ja) | 1990-05-07 | 1999-10-12 | ミヤリサン株式会社 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
US5436002A (en) | 1991-01-29 | 1995-07-25 | Mycogen Corporation | Bacillus thuringiensisisolate PS201T6 toxin |
RU2035186C1 (ru) | 1992-07-09 | 1995-05-20 | Семен Рафаилович Резник | Профилактический биопрепарат споролакт |
CA2146747C (en) | 1992-10-09 | 2006-12-19 | Brian A. Naughton | Liver reserve cells |
US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
DE69635496T2 (de) | 1995-09-15 | 2006-07-27 | Gerding, Dale N., Chicago | Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen |
AUPO430496A0 (en) | 1996-12-19 | 1997-01-23 | Arnott's Biscuits Limited | Prebiotics and probiotics |
US5965128A (en) | 1997-08-13 | 1999-10-12 | University Of Georgia Research Foundation Inc. | Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli |
US5951977A (en) | 1997-10-14 | 1999-09-14 | The United States Of America, As Represented By The Secretary Of Agriculture | Competitive exclusion culture for swine |
US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US6589771B1 (en) | 1999-10-28 | 2003-07-08 | Immunom Technologies, Inc. | Methods for arousing dormant bacteria |
US20030118547A1 (en) | 2000-01-27 | 2003-06-26 | Vandenberg Grant William | Composition for intestinal delivery |
US6613549B2 (en) | 2000-02-10 | 2003-09-02 | Urex Biotech, Inc. | Probiotic therapy for newborns |
US20020013270A1 (en) | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
NZ526748A (en) | 2000-11-30 | 2006-03-31 | Bio Balance Corp | Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
NZ529910A (en) | 2001-05-04 | 2007-03-30 | Univ Florida | Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor |
ITMI20011632A1 (it) | 2001-07-27 | 2003-01-27 | Sanofi Synthelabo | Composizione solida contenente spore di batteri non patogeni del genere bacillus |
GB0130789D0 (en) | 2001-12-21 | 2002-02-06 | King S College London | Application of spores |
US8383342B2 (en) | 2002-04-24 | 2013-02-26 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
GB0212975D0 (en) | 2002-06-06 | 2002-07-17 | Mars Uk Ltd | Mammalian animal composition |
AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
AU2003303894A1 (en) | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
CA2559596A1 (en) | 2003-03-13 | 2004-11-25 | Universite De Moncton (Bureau De Soutien A L'innovation) | Antioxidant producing bacterium and uses thereof |
WO2004093908A2 (en) | 2003-04-23 | 2004-11-04 | Medarex, Inc. | Compositions and methods for the therapy of inflammatory bowel disease |
US20060046246A1 (en) | 2003-04-24 | 2006-03-02 | Qiandong Zeng | Genus, group, species and/or strain specific 16S rDNA sequences |
WO2004104175A2 (en) | 2003-05-14 | 2004-12-02 | University Of Georgia Research Foundation, Inc. | Probiotic bacteria and methods |
JP2007518693A (ja) | 2003-08-18 | 2007-07-12 | ザ バイオ バランス コーポレイション | 安定な液体プロバイオティクス組成物、その調製および適用 |
US7731976B2 (en) | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
US20050048515A1 (en) | 2003-08-29 | 2005-03-03 | Garner Bryan E. | Methods for detecting and quantifying specific probiotic microorganisms in animal feed |
US20050239706A1 (en) | 2003-10-31 | 2005-10-27 | Washington University In St. Louis | Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
CN1913787B (zh) | 2004-02-03 | 2014-11-26 | 增值研究合伙有限公司 | 在动物中促进生长的活体细菌的应用 |
US7632520B2 (en) | 2004-02-16 | 2009-12-15 | Sanjeev Khandelwal | Synergistic antibacterial formulation and to a method of making the same |
US7854927B2 (en) | 2004-05-11 | 2010-12-21 | Ganeden Biotech, Inc. | Methods and compositions for the dietary management of autoimmune disorders |
US20090197249A1 (en) | 2004-11-01 | 2009-08-06 | George Mason University | Compositions and methods for diagnosing colon disorders |
PL1812585T3 (pl) | 2004-11-01 | 2015-03-31 | Erber Ag | Bakteriofagi jako czynniki selekcyjne |
US20060188523A1 (en) | 2005-01-10 | 2006-08-24 | Zhiheng Pei | Methods for diagnosing and treating chronic tonsillitis |
US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
ES2607988T3 (es) | 2005-05-31 | 2017-04-05 | Iams Europe B.V. | Bifidobacterias probióticas felinas |
US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
DK3067057T3 (da) | 2005-09-28 | 2023-02-13 | Nordic Rebalance As | Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
WO2007136553A2 (en) | 2006-05-18 | 2007-11-29 | Biobalance Llc | Bacterial strains, compositions including same and probiotic use thereof |
JP5019563B2 (ja) | 2006-06-16 | 2012-09-05 | 旭化成ケミカルズ株式会社 | 腸内細菌賦活剤 |
JP2009541298A (ja) | 2006-06-20 | 2009-11-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 胃腸障害を処置するための電子カプセル |
TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
EE05459B1 (et) | 2006-12-08 | 2011-08-15 | Tartu �likool | Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon |
EP2102350A4 (en) | 2006-12-18 | 2012-08-08 | Univ St Louis | INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER |
DE102006062250A1 (de) | 2006-12-22 | 2008-06-26 | Roland Saur-Brosch | Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden |
WO2008083157A2 (en) | 2006-12-29 | 2008-07-10 | Washington University In St. Louis | Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject |
CN102316885A (zh) | 2007-09-12 | 2012-01-11 | 塔尔甘塔治疗公司 | 通过奥利万星给药抑制艰难梭菌的方法 |
US8469648B2 (en) * | 2007-10-24 | 2013-06-25 | T&T Engineering Services | Apparatus and method for pre-loading of a main rotating structural member |
JP2011503232A (ja) | 2007-11-20 | 2011-01-27 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 免疫応答の調節 |
US8236508B2 (en) | 2008-01-29 | 2012-08-07 | Drexel University | Detecting and measuring live pathogens utilizing a mass detection device |
US8021654B2 (en) | 2008-03-14 | 2011-09-20 | Danisco A/S | Methods of treating pigs with Bacillus strains |
US20120021921A1 (en) | 2008-04-01 | 2012-01-26 | Scott David L | Process and method for monitoring gastrointestinal microbiota |
CN102940652B (zh) | 2008-05-28 | 2015-03-25 | 青岛东海药业有限公司 | 两形真杆菌制剂及其应用 |
JP2011528117A (ja) | 2008-07-15 | 2011-11-10 | メタノミクス ヘルス ゲーエムベーハー | 胃バイパス及びそれに関連する状態を診断する手段及び方法 |
CN102131928A (zh) | 2008-08-26 | 2011-07-20 | 奥林巴斯株式会社 | 粪便试样的调制方法、粪便试样调制用溶液、及粪便采集用试剂盒 |
WO2010030997A1 (en) | 2008-09-12 | 2010-03-18 | The Washington University | Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss |
EP2337569A4 (en) | 2008-09-25 | 2013-04-03 | Univ New York | COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE GASTROINTESTINAL, SKIN AND NASAL MICROBIOTA |
US9340569B2 (en) | 2008-11-03 | 2016-05-17 | Tufts University | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth |
GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
IT1393931B1 (it) | 2009-02-25 | 2012-05-17 | Neuroscienze Pharmaness S C A R L | Composizione di spore di batteri non patogeni |
US20120128633A1 (en) | 2009-04-30 | 2012-05-24 | Campagnie Gervaise Donone | Use of collinsella aerofaciens for reducing bloating |
EP2419114B2 (en) | 2009-05-01 | 2019-02-27 | UAS Laboratories LLC | Bacterial compositions for prophylaxis and treatment of degenerative disease |
US9050276B2 (en) | 2009-06-16 | 2015-06-09 | The Trustees Of Columbia University In The City Of New York | Autism-associated biomarkers and uses thereof |
US20120264637A1 (en) | 2009-06-26 | 2012-10-18 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
JP5795579B2 (ja) | 2009-06-26 | 2015-10-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 系統発生分析のための方法およびシステム |
WO2011005756A1 (en) | 2009-07-06 | 2011-01-13 | Puretech Ventures, Llc | Delivery of agents targeted to microbiota niches |
AU2010285068B2 (en) | 2009-08-18 | 2015-05-28 | Nestec S.A. | A nutritional composition comprising Lactococcus strains and reducing allergy symptoms, especially in infants and children. |
WO2011022542A2 (en) | 2009-08-19 | 2011-02-24 | Puretech Ventures, Llc | Administration of factors normally present in a microbial niche to improve health |
US20120149584A1 (en) | 2009-08-21 | 2012-06-14 | Bernat Olle | Methods of diagnosing and treating microbiome-associated disease using interaction network parameters |
GB0916335D0 (en) | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
WO2011036539A1 (en) | 2009-09-23 | 2011-03-31 | Borody Thomas J | Therapy for enteric infections |
EP2486143A1 (en) * | 2009-10-05 | 2012-08-15 | AAK Patent B.V. | Methods for diagnosing irritable bowel syndrome |
US20110081320A1 (en) | 2009-10-06 | 2011-04-07 | Nubiome, Inc. | Treatment/Cure of Autoimmune Disease |
WO2011046616A2 (en) | 2009-10-15 | 2011-04-21 | New York University | Methods for modulating bacterial infection |
IN2012DN03632A (zh) | 2009-11-12 | 2015-06-26 | Nestec Sa | |
AU2010339573B2 (en) | 2009-12-31 | 2014-08-28 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
US9492487B2 (en) | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
SI3564357T1 (sl) | 2010-02-01 | 2022-09-30 | Rebiotix, Inc. | Bakterioterapija Clostridium Difficile colitisa |
WO2011103123A2 (en) | 2010-02-16 | 2011-08-25 | Arizona Technology Enterprises | Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
EP2542690A2 (en) | 2010-03-01 | 2013-01-09 | Institut National de la Recherche Agronomique | Method of diagnostic of inflammatory bowel diseases |
US20130005586A1 (en) | 2010-03-01 | 2013-01-03 | Stanislav Ehrlich | Method of diagnostic of obesity |
IT1398553B1 (it) | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
WO2011113801A1 (en) | 2010-03-16 | 2011-09-22 | Universiteit Gent | Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
US8951512B2 (en) | 2010-05-04 | 2015-02-10 | New York University | Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota |
WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
SI2591114T1 (sl) | 2010-07-06 | 2016-10-28 | Glaxosmithkline Biologicals S.A. | Imunizacija velikih sesalcev z majhnimi odmerki RNA |
BR112013001107B1 (pt) | 2010-07-16 | 2022-01-25 | The Board Of Trustees Of The University Of Arkansas | Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais |
FI20105825A (fi) | 2010-07-26 | 2012-01-27 | Suomen Punainen Risti Veripalvelu | Veriryhmästatuksen käyttö III |
JP2013537531A (ja) | 2010-08-04 | 2013-10-03 | トーマス・ジュリアス・ボロディ | 糞便細菌叢移植のための組成物ならびにそれを作製および使用する方法ならびにそれを送達するためのデバイス |
US9386793B2 (en) | 2010-08-20 | 2016-07-12 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
WO2012033814A2 (en) | 2010-09-10 | 2012-03-15 | Viropharma Incorporated | Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use |
US20130259899A1 (en) | 2010-10-04 | 2013-10-03 | Allen-Vercoe, Emma Molecular And Cellular Biology University Of Guelph | Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
WO2012064981A2 (en) | 2010-11-10 | 2012-05-18 | National Jewish Health | Methods to test allergic conditions |
US20120064592A1 (en) | 2011-01-26 | 2012-03-15 | Qteros, Inc. | Biocatalysts synthesizing deregulated cellulases |
EP2672980B1 (en) | 2011-02-09 | 2017-12-06 | Lavivo AB | Synbiotic compositions for restoration and reconstitution of gut microbiota |
AR085409A1 (es) | 2011-02-25 | 2013-10-02 | Tricorder Diagnostics Llc | Firmas microbianas como indicadores de exposicon a radiacion |
WO2012122522A2 (en) | 2011-03-09 | 2012-09-13 | Washington University | Cultured collection of gut microbial community |
AU2012225305B2 (en) | 2011-03-09 | 2017-06-08 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
WO2012142605A1 (en) * | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
US20120276056A1 (en) | 2011-04-26 | 2012-11-01 | Wieslaw Janusz Bochenek | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine |
US20140179726A1 (en) | 2011-05-19 | 2014-06-26 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
US9579353B2 (en) | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
WO2013008102A2 (en) | 2011-07-14 | 2013-01-17 | R.E.D. Laboratories N.V../ S.A. | Methods and compositions for evaluating and/or treating chronic immune diseases |
US20130022575A1 (en) | 2011-07-19 | 2013-01-24 | Microbial Rx | Systems and methods of replacing intestinal flora |
US20140348811A1 (en) | 2011-07-27 | 2014-11-27 | Max International, Llc | Compositions comprising sugar-cysteine products |
WO2013019896A1 (en) | 2011-08-01 | 2013-02-07 | Symbiotix Biotherapies, Inc. | Platform for identifying and/or characterizing immunomodulatory agents |
EP2753187B1 (en) | 2011-08-30 | 2018-10-24 | Caelus Pharmaceuticals B.V. | Method for preventing and/or treating insulin resistance |
CA2848762C (en) | 2011-09-14 | 2021-07-27 | Queen's University At Kingston | Method for treatment of disorders of the gastrointestinal system |
WO2013066369A2 (en) | 2011-10-03 | 2013-05-10 | The Regents Of The University Of Michigan | Methods for detecting graft-versus-host disease |
US20130121968A1 (en) | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
KR20140082964A (ko) | 2011-10-11 | 2014-07-03 | 아힘 바이오테라퓨틱스 에이비 | 혐기성 조건으로 배양된 인간 장내 미생물을 포함하는 조성물 |
EP2785828B1 (en) | 2011-12-01 | 2020-04-08 | The University of Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
GB201201766D0 (en) | 2012-02-01 | 2012-03-14 | Imp Innovations Ltd | Method |
US20150125883A1 (en) | 2012-04-30 | 2015-05-07 | Washington University | Method of isolating and characterizing microorganisms that are targets of host immune responses |
EP2850202B1 (en) | 2012-05-18 | 2020-03-11 | Genome Research Limited | Methods and groups |
CA3172599A1 (en) | 2012-05-25 | 2013-11-28 | Sloan Kettering Institute For Cancer Research | Anti-ceramide antibody and antigen binding fragment thereof |
WO2013176774A1 (en) | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
EP2684469A1 (en) | 2012-07-13 | 2014-01-15 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth |
DK3628161T3 (da) | 2012-11-23 | 2023-05-30 | Seres Therapeutics Inc | Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
WO2014121304A1 (en) | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
EP2971148A4 (en) | 2013-03-14 | 2016-08-17 | Seres Therapeutics Inc | METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS |
JP2016519664A (ja) | 2013-03-15 | 2016-07-07 | セレス セラピューティクス インコーポレイテッド | ネットワークを基にした微生物組成物及び方法 |
CN105142654B (zh) | 2013-05-03 | 2020-04-10 | 雀巢产品有限公司 | 肠小型生物群中的毛螺菌科和与体重的关联 |
WO2015018308A1 (en) | 2013-08-06 | 2015-02-12 | BGI Shenzhen Co.,Limited | Biomarkers for colorectal cancer |
KR102515850B1 (ko) | 2013-11-25 | 2023-03-30 | 세레스 테라퓨틱스, 인코포레이티드 | 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도 |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
BR112018000204A2 (pt) | 2015-07-08 | 2018-09-04 | Seres Therapeutics Inc | métodos de tratamento de colite |
US10300043B2 (en) | 2015-08-12 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof |
WO2017074257A1 (en) | 2015-10-26 | 2017-05-04 | Nanyang Technological University | Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents |
FI3380108T3 (fi) | 2015-11-24 | 2023-03-03 | Seres Therapeutics Inc | Suunniteltuja bakteerikoostumuksia |
WO2017091753A1 (en) | 2015-11-25 | 2017-06-01 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization |
ES2962302T3 (es) | 2015-12-14 | 2024-03-18 | Metabogen Ab | Tratamiento de la colestasis intrahepática y hepatopatías relacionadas |
US11116804B2 (en) | 2016-03-14 | 2021-09-14 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
MX2020003605A (es) | 2017-10-03 | 2020-11-06 | Seres Therapeutics Inc | Manipulación del metabolismo de triptamina. |
WO2019089643A1 (en) | 2017-10-30 | 2019-05-09 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
EP3801065A4 (en) | 2018-05-24 | 2022-11-02 | Seres Therapeutics, Inc. | DESIGN OF BACTERIAL COMPOSITIONS AND THEIR USE |
-
2014
- 2014-03-17 JP JP2016502561A patent/JP2016519664A/ja active Pending
- 2014-03-17 AU AU2014232370A patent/AU2014232370B2/en active Active
- 2014-03-17 WO PCT/US2014/030817 patent/WO2014145958A2/en active Application Filing
- 2014-03-17 CA CA2906921A patent/CA2906921A1/en active Pending
- 2014-03-17 US US14/777,252 patent/US10076546B2/en active Active
- 2014-03-17 EP EP14763266.5A patent/EP2967077A4/en active Pending
-
2016
- 2016-07-18 HK HK16108497.3A patent/HK1220326A1/zh unknown
-
2018
- 2018-05-25 US US15/990,539 patent/US10881696B2/en active Active
-
2019
- 2019-01-31 AU AU2019200628A patent/AU2019200628B2/en active Active
- 2019-05-08 JP JP2019088423A patent/JP7136743B2/ja active Active
-
2021
- 2021-01-04 US US17/140,385 patent/US11666612B2/en active Active
- 2021-05-25 AU AU2021203396A patent/AU2021203396A1/en active Pending
-
2022
- 2022-09-01 JP JP2022138978A patent/JP2022188020A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2014145958A3 (en) | 2015-01-29 |
EP2967077A2 (en) | 2016-01-20 |
AU2014232370B2 (en) | 2018-11-01 |
US20210252079A1 (en) | 2021-08-19 |
AU2014232370A1 (en) | 2015-11-05 |
WO2014145958A4 (en) | 2015-04-02 |
JP2016519664A (ja) | 2016-07-07 |
JP2022188020A (ja) | 2022-12-20 |
US10881696B2 (en) | 2021-01-05 |
US11666612B2 (en) | 2023-06-06 |
US20160030494A1 (en) | 2016-02-04 |
EP2967077A4 (en) | 2016-09-14 |
AU2019200628B2 (en) | 2021-02-25 |
US10076546B2 (en) | 2018-09-18 |
AU2021203396A1 (en) | 2021-06-24 |
AU2019200628A1 (en) | 2019-02-21 |
WO2014145958A2 (en) | 2014-09-18 |
JP7136743B2 (ja) | 2022-09-13 |
CA2906921A1 (en) | 2014-09-18 |
US20180353554A1 (en) | 2018-12-13 |
JP2019163285A (ja) | 2019-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220326A1 (zh) | 基於網絡微生物組成和方法 | |
IL273205A (en) | Preparations and methods | |
HK1218837A1 (zh) | 組合物和方法 | |
HK1218560A1 (zh) | 組成與方法 | |
IL250998A0 (en) | Microbial compositions and methods | |
GB2520795B (en) | Compositions and methods | |
EP2978300A4 (en) | COMPOSITIONS AND METHODS FOR INCREASING MICROBIAL STABILITY | |
LT3066201T (lt) | Su crispr susiję būdai ir kompozicijos su valdančiomis grnr | |
IL245036A0 (en) | Pesticides and related methods | |
GB201308072D0 (en) | Compositions and methods | |
GB201317286D0 (en) | Composition and Use | |
ZA201508529B (en) | Bacterial fermentation methods and compositions | |
IL245035A0 (en) | Pesticides and related methods | |
GB201321693D0 (en) | Composition and uses thereof | |
SG11201601130YA (en) | Film-forming composition and film-forming method using same | |
GB201305414D0 (en) | Method and composition | |
IL245033A0 (en) | Pesticides and related methods | |
IL276126B (en) | Preparations containing l-4-chloroquinonerine and their uses | |
GB201305813D0 (en) | Compositions and methods | |
EP3007720A4 (en) | COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF | |
IL245034A0 (en) | Pesticides and related methods | |
EP2964610A4 (en) | VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF | |
EP2969003A4 (en) | METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS | |
GB201313803D0 (en) | Fungicidal composition and method | |
GB201322617D0 (en) | Methods and compositions |